Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study

Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study

Background: Laryngopharyngeal reflux disease (LPRD) is an extraesophageal syndromic manifestation of gastroesophageal reflux disease (GERD). Despite the increasing incidence of and concern about LPRD, treatment with proton pump inhibitors (PPIs) is unsatisfactory. Here, LPRD was treated with Tonghua...

Full description

Bibliographic Details
Main Authors: Yading Li, Mingxian Zheng, Yi Wang, Gaofan Xu, Yunyun He, Yue Wu, Xiao Wang, Yuyang Liu, Yujie Jiang, Xiaowen Liu, Yangyang Meng, Yixuan Yap, Shengliang Zhu, Cong He, Bingduo Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Pharmacology
Subjects:
laryngopharyngeal reflux disease
THLY granules
rabeprazole
integrated Chinese and Western medicine
efficacy evaluation
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1275740/full

Similar Items

Similar Items